Lee JS - Search Results

1

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.

Fossella FV, DeVore R, Kerr RN, Crawford J, Natale RR, Dunphy F, Kalman L, Miller V, Lee JS, Moore M, Gandara D, Karp D, Vokes E, Kris M, Kim Y, Gamza F, Hammershaimb L. Fossella FV, et al. Among authors: lee js. J Clin Oncol. 2000 Jun;18(12):2354-62. doi: 10.1200/JCO.2000.18.12.2354. J Clin Oncol. 2000. PMID: 10856094 Clinical Trial.

2

Systemic treatment of non-small-cell lung cancer.

Lenzi R, Fossella FV, Lee JS. Lenzi R, et al. Among authors: lee js. Compr Ther. 1992 Mar;18(3):27-30. Compr Ther. 1992. PMID: 1315236 Review. No abstract available.

3

Phase II study of combination therapy with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small-cell lung cancer.

Shin DM, Dhingra HM, Lee JS, Fossella FV, Murphy WK, Hong WK. Shin DM, et al. Among authors: lee js. Am J Clin Oncol. 1992 Jun;15(3):194-9. doi: 10.1097/00000421-199206000-00003. Am J Clin Oncol. 1992. PMID: 1317094 Clinical Trial.

4

Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer.

Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman SM, Shin DM, Dimery IW, Glisson BS, Hong WK. Lee JS, et al. J Natl Cancer Inst. 1992 Jul 1;84(13):1039-40. doi: 10.1093/jnci/84.13.1039. J Natl Cancer Inst. 1992. PMID: 1318977 Clinical Trial. No abstract available.

5

The incidence of second primary tumors in long-term survivors of small-cell lung cancer.

Heyne KH, Lippman SM, Lee JJ, Lee JS, Hong WK. Heyne KH, et al. Among authors: lee js, lee jj. J Clin Oncol. 1992 Oct;10(10):1519-24. doi: 10.1200/JCO.1992.10.10.1519. J Clin Oncol. 1992. PMID: 1328547

6

Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.

Shirinian M, Lee JS, Dhingra HH, Greenberg J, Hong WK. Shirinian M, et al. Among authors: lee js. Semin Oncol. 1992 Feb;19(1 Suppl 1):49-53. Semin Oncol. 1992. PMID: 1329212

7

Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report.

Shirinian M, Lee JS, Dhingra HH, Greenberg J, Hong WK. Shirinian M, et al. Among authors: lee js. Semin Oncol. 1992 Dec;19(6 Suppl 12):58-63. Semin Oncol. 1992. PMID: 1336623 Clinical Trial.

8

Study of multidrug resistance (mdr1) gene in non-small-cell lung cancer.

Shin HJ, Lee JS, Hong WK, Shin DM. Shin HJ, et al. Among authors: lee js. Anticancer Res. 1992 Mar-Apr;12(2):367-70. Anticancer Res. 1992. PMID: 1374598

9

Combination of 5-fluorouracil and recombinant interferon alpha-2B in advanced gastric cancer. A phase I study.

Lee KH, Lee JS, Suh C, Lee YS, Min YI, Ahn SH, Park KC, Kim SK, Kim SH. Lee KH, et al. Among authors: lee js, lee ys. Am J Clin Oncol. 1992 Apr;15(2):141-5. doi: 10.1097/00000421-199204000-00009. Am J Clin Oncol. 1992. PMID: 1553902 Clinical Trial.

10

Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer.

Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman SM, Shin DM, Dimery IW, Glisson BS, Hong WK. Lee JS, et al. Cancer. 1991 Sep 1;68(5):959-64. doi: 10.1002/1097-0142(19910901)68:5<959::aid-cncr2820680508>3.0.co;2-v. Cancer. 1991. PMID: 1655220 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,841 results

Search Page

Filters